Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

2.390

-0.080 (-3.24%)

At close: Feb 27, 2026, 4:00 PM EST

2.361

-0.029 (-1.23%)

After-hours: Feb 27, 2026, 7:53 PM EST

Zentalis Pharmaceuticals Employees

Zentalis Pharmaceuticals had 166 employees as of December 31, 2024. The number of employees decreased by 2 or -1.19% compared to the previous year.

Employees

166

Change (1Y)

-2

Growth (1Y)

-1.19%

Revenue / Employee

$161,837

Profits / Employee

-$899,494

Market Cap

154.75M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	166	-2	-1.19%
Dec 31, 2023	168	12	7.69%
Dec 31, 2022	156	-21	-11.86%
Dec 31, 2021	177	53	42.74%
Dec 31, 2020	124	62	100.00%
Sep 30, 2020	110	48	77.42%
Jun 30, 2020	75	-	-
Mar 31, 2020	64	-	-
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Karyopharm Therapeutics	279
Sangamo Therapeutics	183
Innate Pharma	174
ProQR Therapeutics	166
Rani Therapeutics Holdings	106
Compugen	74
Acumen Pharmaceuticals	61
Corbus Pharmaceuticals Holdings	28